| Phase I Trial of GR1803 Injection in Patients With RRMM (NCT07102706) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-05-27 |
| Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors (NCT05309512) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2022-05-27 |
| CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer (NCT05251714) | Treadwell Therapeutics, Inc | 2022-05-27 |
| Comparing the Effects of Psilocin and Psilocybin in Healthy Adults (NCT05317689) | University of California, San Francisco | 2022-05-26 |
| Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia (NCT05421689) | University of California, Davis | 2022-05-26 |
| A Study of LY3502970 in Healthy Overweight and Obese Participants (NCT05313802) | Eli Lilly and Company | 2022-05-26 |
| Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects (NCT05381870) | The Affiliated Hospital of Qingdao University | 2022-05-26 |
| A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors. (NCT06237400) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-05-26 |
| Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours (NCT05255484) | LaNova Medicines Limited | 2022-05-26 |
| JINZHEN for Treatment of Mild to Moderate COVID-19 (NCT05092503) | Lianyungang Kanion Group, Ltd. | 2022-05-26 |
| Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects (NCT06360445) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2022-05-26 |
| Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome (NCT06285214) | Imbrium Therapeutics | 2022-05-26 |
| Alleviation of Common Cold Symptoms (NCT06106880) | Applied Biological Laboratories Inc | 2022-05-25 |
| Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants (NCT05347979) | Corcept Therapeutics | 2022-05-25 |
| A Study Investigating the Safety, Absorption, and Elimination of Radioactively Labeled Etrumadenant, a New Compound in the Treatment of Cancer (NCT05411146) | Arcus Biosciences, Inc. | 2022-05-25 |
| Chidamide Bridging for CAR-T Therapy (NCT05370547) | Chinese PLA General Hospital | 2022-05-25 |
| Anthrax AV7909 Liquid vs Lyophilized (NCT04660201) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-25 |
| CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC (NCT04739358) | Criterium, Inc. | 2022-05-25 |
| A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants (NCT05392530) | Actelion | 2022-05-25 |
| A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma (NCT05338775) | Janssen Research & Development, LLC | 2022-05-25 |
| Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies (NCT05410041) | Beijing Boren Hospital | 2022-05-25 |
| Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS (NCT05342584) | Montefiore Medical Center | 2022-05-25 |
| A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma (NCT05301764) | Lyvgen Biopharma Holdings Limited | 2022-05-25 |
| A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) (NCT05414786) | International AIDS Vaccine Initiative | 2022-05-25 |
| A Study of YL201 in Patients With Advanced Solid Tumors (NCT05434234) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2022-05-25 |
| A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants (NCT05873764) | Pfizer | 2022-05-25 |
| Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin (NCT05379790) | Erasmus Medical Center | 2022-05-25 |
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors (NCT05396300) | Weijia Fang, MD | 2022-05-25 |
| Maribavir Food-Effect Study in Healthy Adults Participants (NCT05382104) | Takeda | 2022-05-25 |
| Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers (NCT05370950) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-25 |
| A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT05077423) | Y-mAbs Therapeutics | 2022-05-25 |
| ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy (NCT05392699) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-05-25 |
| Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults (NCT04996719) | Mayo Clinic | 2022-05-24 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects (NCT05369767) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-05-24 |
| A Study of Modified mRNA Vaccines in Healthy Adults (NCT05397223) | ModernaTX, Inc. | 2022-05-24 |
| KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) (NCT05454462) | Orvida Pharma (formerly Kamari Pharma) | 2022-05-24 |
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Study of Alveolar Bone Preservation Using Photobiomodulation Combined With Grafting With Scaffold Biomaterial (NCT06150456) | University of Nove de Julho | 2022-05-24 |
| Influenza Human Challenge Model (NCT05332899) | Emory University | 2022-05-24 |
| GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (NCT05242146) | GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2022-05-24 |
| A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis (NCT05252533) | Janssen Research & Development, LLC | 2022-05-24 |
| A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants (NCT05395104) | Shionogi | 2022-05-24 |
| Multiple Ascending Dose Study of CM338 in Healthy Volunteers (NCT05371379) | Keymed Biosciences Co.Ltd | 2022-05-24 |
| GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors (NCT05430373) | Grit Biotechnology | 2022-05-23 |
| Biofeedback and Hydrogen Water as Treatments for Chronic Fatigue Syndrome (NCT05397626) | Stony Brook University | 2022-05-23 |
| Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant (NCT04815356) | National Cancer Institute (NCI) | 2022-05-23 |
| A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS (NCT05351671) | ReAlta Life Sciences, Inc. | 2022-05-23 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001) (NCT05354453) | Boehringer Ingelheim | 2022-05-23 |
| Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults (NCT05292391) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-23 |
| Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors (NCT05740215) | Shandong New Time Pharmaceutical Co., LTD | 2022-05-23 |
| Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies (NCT05327023) | National Cancer Institute (NCI) | 2022-05-23 |
| A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years (NCT05381142) | Bayer | 2022-05-23 |
| NT-I7 for Kaposi Sarcoma in Patients With or Without HIV (NCT04893018) | Fred Hutchinson Cancer Center | 2022-05-23 |
| GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19) (NCT05182567) | GeneOne Life Science, Inc. | 2022-05-23 |
| Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC (NCT05287256) | Johns Hopkins University | 2022-05-23 |
| A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects (NCT05382546) | Nuance Pharma (shanghai) Co., Ltd | 2022-05-23 |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia (NCT05304377) | Enliven Therapeutics | 2022-05-22 |
| The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants (NCT05829551) | Guangdong Raynovent Biotech Co., Ltd | 2022-05-20 |
| Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group (NCT06070571) | Deraya University | 2022-05-20 |
| Study of F527 in Patients With Relapsed or Refractory Lymphoma (NCT05293028) | Shandong New Time Pharmaceutical Co., LTD | 2022-05-20 |
| Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease (NCT05422885) | Lewis Lipsitz | 2022-05-20 |
| Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) (NCT04745403) | Lion TCR Pte. Ltd. | 2022-05-20 |
| A Study in Patients With Advanced Breast Cancer (NCT04942054) | Sun Pharma Advanced Research Company Limited | 2022-05-20 |
| Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet® (NCT06073600) | Reseach Laboratory of Clinical and Experimental Pharmacology | 2022-05-20 |
| A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants (NCT05367388) | Apollomics Inc. | 2022-05-20 |
| Sympathetic Mechanisms in Obesity-Crossover Design (NCT05312892) | Vanderbilt University Medical Center | 2022-05-20 |
| Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors (NCT05479812) | Werewolf Therapeutics, Inc. | 2022-05-20 |
| A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors (NCT05339685) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-05-20 |
| A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma (NCT05312411) | Seattle Children's Hospital | 2022-05-20 |
| IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor (NCT05359445) | Immatics Biotechnologies GmbH | 2022-05-19 |
| GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma (NCT05352542) | jianming xu | 2022-05-19 |
| Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy (NCT05507697) | Wuhan Central Hospital | 2022-05-19 |
| Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors (NCT05225584) | Kymera Therapeutics, Inc. | 2022-05-19 |
| A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults (NCT05274659) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2022-05-19 |
| A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer (NCT05275777) | National University Hospital, Singapore | 2022-05-19 |
| dMAbs for Prevention of COVID-19 (NCT05293249) | Pablo Tebas | 2022-05-19 |
| A Study of AL8326 in Non-Small Cell Lung Cancer (NCT06794957) | Advenchen Laboratories, LLC | 2022-05-19 |
| A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (NCT05364944) | Debiopharm International SA | 2022-05-18 |
| Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) (NCT04234867) | Kinderkrankenhaus auf der Bult | 2022-05-18 |
| First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent (NCT05413668) | Reveal Pharmaceuticals Inc. | 2022-05-18 |
| Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer (NCT05293964) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-18 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects (NCT05384262) | AstraZeneca | 2022-05-18 |
| Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects (NCT05330208) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-05-18 |
| A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants (NCT05366738) | Phathom Pharmaceuticals, Inc. | 2022-05-18 |
| Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers (NCT05572281) | Vanda Pharmaceuticals | 2022-05-18 |
| Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC (NCT04467723) | University of Kansas Medical Center | 2022-05-18 |
| Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections (NCT05138822) | GlaxoSmithKline | 2022-05-18 |
| A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors (NCT05528055) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-18 |
| Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD) (NCT05429788) | Receptor Life Sciences | 2022-05-18 |
| Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA (NCT05181735) | Groupe Francophone des Myelodysplasies | 2022-05-18 |
| Investigation of the Pharmacokinetic Profile of CBD (NCT05269706) | Yasmin Hurd | 2022-05-18 |
| A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma (NCT05055063) | M.D. Anderson Cancer Center | 2022-05-18 |
| A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. (NCT05155709) | Novartis Pharmaceuticals | 2022-05-17 |
| Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model (NCT05289076) | University Hospital, Linkoeping | 2022-05-17 |
| A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor (NCT05332574) | Genor Biopharma Co., Ltd. | 2022-05-17 |
| A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (NCT05346484) | Imugene Limited | 2022-05-17 |
| Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older (NCT05373485) | CanSino Biologics Inc. | 2022-05-17 |
| A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets (NCT05308654) | AbbVie | 2022-05-17 |
| Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. (NCT05271318) | TILT Biotherapeutics Ltd. | 2022-05-17 |
| A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain (NCT05298306) | Lateral Pharma Pty Ltd | 2022-05-17 |